Pablo J. Cagnoni, President and Global Head of R&D at Incyte Corp, sold 10,803 shares of common stock in August 2026. The sale was conducted under a Rule 10b5-1 trading plan.
Incyte Corp President Sells 10,803 Shares Under 10b5-1 Plan
INCYInsider TradingBiotechnologyExecutive SalesPharmaceuticals

